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530Fighting Malaria:
Mosquitoes Know How
The mosquito fights malaria to the incidental benefit
of humans. In this issue, Frolet et al. (2006) define
states of ‘‘basal’’ and ‘‘induced’’ immunity and show
that a single genetic manipulation can rid the mos-
quito of a noxious parasite.
Protozoa of the Plasmodium genus have but one ge-
nome, yet adopt many guises and live in many worlds.
We have come to see P. falciparum as a predator that
kills millions of people every year. We dread its ability
to evade chemotherapy through mutation and selec-
tion. But there is a ray of hope, because Plasmodium
species are also prey, both in mammals and in insects.
In this optimistic view, the frailties of the parasite are
many. We know that the virulence of some Plasmodium
species is much attenuated by well-placed mutations
that occur in mammals (Hill, 1999). P. vivax has become
a rather mild pathogen, and in fact has been neutralized
in the human host in large parts of the world as a result
of the fixation of null alleles of the Duffy blood-group an-
tigen (also known as DARC). And, of course, mutations
affecting hemoglobin, glucose-6-phosphate dehydro-
genase (G-6-PD), and other proteins are known to offer
resistance to P. falciparum, though sometimes at a dis-
agreeable cost to the host.
Perhaps because they are transmitted by mosqui-
toes, it is easy for us to forget that Plasmodium species
are no friends to mosquitoes. At the least, mosquitoes
do not appear to derive any benefit from serving as
a host for Plasmodium, and as emphasized by a number
of recent papers, they have developed mechanisms for
resistance to infection (Vernick et al., 2005; Riehle et al.,
2006; Dong et al., 2006) Might mosquitoes be even more
capable of thwarting Plasmodium than mammals, given
their huge numbers in nature, their short generation
time, and their consequent potential for rapid evolution-
ary change?
In this issue of Immunity, Frolet et al. (2006) have
taken some very important steps toward an under-
standing of mosquito resistance mechanisms in their
analysis of ookinete killing by Anopheles gambiae, the
African malaria mosquito. Here they offer a profound
analysis of the insect side of the equation and empha-
size not only key molecules but also the issue of timing.
When mosquitoes take a blood meal from a mammal,
gametocytes harbored within erythrocytes mature into
gametes in the blood bolus within 15 min. They then
fuse to make a zygote, which soon divides to yield
daughter cells. Sixteen hours after blood feeding,
P. berghei (a mouse malaria parasite that is widely con-
sidered to be an excellent model of the human pathogen
P. falciparum) has become a motile ookinete, deter-
mined to invade the midgut epithelium. Crossing the ep-
ithelial barrier asynchronously, the ookinetes reach thebasal labyrinth over a period of several hours and then
come into contact with insect blood, which contains de-
fense factors that might potentially kill them. However,
when completed, invasion somehow induces a switch
in the developmental program of the parasite, leading
to its transformation into a young oocyst. The oocyst ul-
timately produces sporozoites that, after invading the
mosquito salivary glands, can infect the mammalian
host at the next bite (Figure 1).
Among the proteins that defend the mosquito is
TEP1, a complement-like molecule shown by Levashina
and colleagues in an earlier study to engage and kill oo-
kinetes. But oocysts are impervious to TEP1, and
hence, P. berghei is vulnerable to TEP1 only for a brief
period time, between penetration of the host epithelium
and its transformation from ookinete to oocyst (Blandin
et al., 2004). The discovery of a key effector—like
TEP1—opens the way to some real understanding: What
controls its synthesis? Is it induced by infection, and
if so, how?
To date, studies of the immune responses of insects
have focused chiefly on inducible defenses, exemplified
by the Toll and Imd pathways, linked to the activation of
two different forms of the transcription factor NF-kB, Dif
and Relish, which in turn stimulate the production of an-
timicrobial peptides, the mainstay of defense in fruit flies
(Royet et al., 2005). The mosquito has a similar repertoire
of proteins with which to respond to bacteria and fungi
(Christophides et al., 2002). The present paper is a land-
mark in the natural history of P. berghei infection be-
cause it shows that defense against P. berghei involves
two component phases. The first, constitutive, ‘‘preinva-
sion’’ phase entails basal production of immune factors,
including TEP1 (the authors refer to this as ‘‘basal immu-
nity’’), which is dependent on two NF-kB factors of
A. gambiae, Rel1 (Dif-like) and Rel2 (Relish-like). In the
late preinvasion phase, TEP1 and other blood-borne
defense factors are depleted. The second, inducible,
‘‘postinvasion’’ phase entails transcriptional activation
of genes encoding multiple defense factors, and occurs
24 hr after infection. Interestingly, although repletion of
some defense factors depends on NF-kB, the repletion
of others (e.g., TEP1) is NF-kB independent.
In one of the remarkable highlights of this paper,
Frolet et al. find that boosting basal immunity by sig-
nal-independent activation of Rel1 through RNAi-medi-
ated depletion of the negative regulator Cactus is suffi-
cient to completely block P. berghei progression to the
oocyst stage. Such a striking phenotype has never been
experimentally induced in the past, and beyond defining
the importance of NF-kB-mediated basal immunity, it
raises a number of interesting questions and opens
a number of doors. Specifically, because we now know
that blocking the expression of one protein (Cactus)
produces complete parasite elimination, what other
proteins might also have nonredundant ‘‘suppressive’’
function, such that their mutational inactivation allows
parasites to flourish? In essence, Frolet et al. have de-
veloped a powerful system to identify unique mosquito
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to further screening (for example, mutagenesis might
be applied to look for resistance, measured by a dimin-
ished ookinete count after an infected blood meal). In
Drosophila, the Cactus-Dif signaling module controls
the expression of hundreds of genes. Frolet et al. have
stressed the requirement for molecules other than
TEP1 for complete abortion of parasite transmission,
and the identification of these molecules is now a new
and obvious challenge in the field.
This study also underlines the central role of a com-
plement-like protein in the antiparasitic defense. In-
deed, complement-like proteins are molecules of
choice both for recognition of infectious agents and
for initiation of immediate effector mechanisms. We
Figure 1. The Ookinete and Its Vulnerability to TEP1
Arising from the fusion of male and female gametocytes, the zygote
yields ookinetes that penetrate the wall of the midgut asynchro-
nously, over a period of 16 to 20 hr. This process is resisted by ‘‘basal
immunity,’’ under the control of transcription factors Rel1 and Rel2,
and leads to a state of ‘‘induced immunity.’’ Induced immunity per-
mits replenishment of parasite-killing factors such as TEP1.are left to wonder how the complement protein recog-
nizes the parasite and how parasite killing is achieved.
It should be mentioned that other molecules are also
required for ookinete killing, e.g., LRIM1, a product of
the family of leucine-rich-repeat immune genes (Osta
et al., 2004), and these also operate through unknown
mechanisms.
The implications of these data in malaria control are
obvious. Rather than targeting the parasite, one might
target the host, upregulating conserved molecules that
enhance basal immunity. Chemicals or fungal spores
that would induce the Rel1 pathway might be used for
this purpose (Blanford et al., 2005). And at least in prin-
ciple, should a key Rel1-dependent defense factor be
identified, it could be used as the basis of an antimalar-
ial transgene. The feasibility of these approaches may
ultimately be judged from experiments performed in
natural populations.
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